Eastroc Beverage (09980) revenue surpassed 20 billion in 2025, with net profit attributable to the mother increasing by 32.72% year-on-year to 4.415 billion.
Dongpeng Beverage (09980) announced its performance in 2025, with revenue of approximately 20.866 billion yuan, a year-on-year increase of 31.81%; the annual profit attributable to the owners of the parent company is approximately 4.415 billion yuan, an increase of 32.72% year-on-year; basic earnings per share is 8.4907 yuan, and a final cash dividend of 25 yuan (tax included) will be distributed for every 10 shares, with an additional 3 shares for every 10 shares issued from capital reserve to all shareholders (no bonus shares). The company's total sales volume exceeded 10 billion bottles, successfully achieving its annual target. At the same time, Dongpeng Beverage has entered the top ten of the global soft drink brand value list, ranking 44th on the Kantar 2025 most valuable Chinese brand ranking.
Eastroc Beverage (09980) announces its performance for 2025, with revenue of approximately 20.866 billion yuan, an increase of 31.81% year-on-year; the annual profit attributable to owners of the parent company is about 4.415 billion yuan, an increase of 32.72% year-on-year; basic earnings per share is 8.4907 yuan, with a proposed final cash dividend of 25 yuan per 10 shares (including tax), and a bonus issue of 3 shares for every 10 shares to all shareholders from the capital reserve fund (no bonus shares). The company's total sales volume has exceeded 10 billion bottles, successfully achieving its target set at the beginning of the year. Additionally, Eastroc Beverage has entered the top ten on the global soft drink brand value list, ranking 44th on the BrandZ 2025 China's Most Valuable Brands list.
The core flagship product "Dongpeng Special Drink" has become the top-selling energy drink in China, with annual revenue of 15.599 billion yuan, becoming the undisputed number one energy drink brand in China; the sports drink "Hydration Now" achieved annual revenue of 3.274 billion yuan, entering the ranks of 3 billion-level flagship products. Products such as "Fruit Tea" and "Dongpeng Da Ka" have performed well, with revenues exceeding 0.5 billion yuan each. The proportion of revenue from non-special drinks has increased from 15.9% in 2024 to 25.2% in 2025. The "1+6" multi-category strategy has achieved its first victory, propelling Eastroc Beverage into the ranks of China's comprehensive beverage companies.
The company continuously expands its national distribution network, with over 4.5 million active terminals, while actively advancing its internationalization strategy, with products now available in over 32 countries and regions. Brand-building initiatives in multiple dimensions include sports sponsorship, e-sports cooperation, and targeted endorsement promotions, effectively enhancing consumer awareness of the brand across all categories. In terms of the supply chain, 10 out of 14 planned production bases have been put into operation, leveraging economies of scale in procurement, automated production, and logistics optimization to sustain cost advantages. The group has its own digital infrastructure, including a five-code integration system and a collaborative supply chain planning platform, to drive channel governance, marketing execution, and precise business decision-making. Through collaborative innovation with industry, academia, and research, as well as the introduction of new products, the company continues to strengthen its innovation capabilities, while also consolidating its organizational foundation with a culture of talent development and growth - "simplicity, integrity, collaboration, and hard work."
While consolidating its domestic market, the company actively pursues a globalization strategy, exploring opportunities in overseas markets. By implementing flexible localized strategies and adjusting product formulas and packaging designs to cater to the preferences of consumers in different regions, Eastroc Beverage has successfully launched locally adapted products in markets such as Malaysia, Vietnam, and Indonesia. In the future, the company plans to further deepen its business presence in Southeast Asia, and leveraging the opportunity of listing in Hong Kong, inject new momentum into the brand's global expansion.
Related Articles

RENRUI HR (06919) released its annual performance report, with a net profit attributable to shareholders of 87.55 million yuan, turning a loss into a profit compared to the previous year.

BOAN BIOTECH (06955) announced its annual performance, with a net profit attributable to shareholders of 7.144 million yuan, a year-on-year decrease of 90.24%.

RUNHUA SERVICE (02455) announced its 2025 annual performance, with a net profit attributable to shareholders of RMB 46.32 million, an increase of 1.7% year-on-year.
RENRUI HR (06919) released its annual performance report, with a net profit attributable to shareholders of 87.55 million yuan, turning a loss into a profit compared to the previous year.

BOAN BIOTECH (06955) announced its annual performance, with a net profit attributable to shareholders of 7.144 million yuan, a year-on-year decrease of 90.24%.

RUNHUA SERVICE (02455) announced its 2025 annual performance, with a net profit attributable to shareholders of RMB 46.32 million, an increase of 1.7% year-on-year.

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


